FBIO - コロナド・バイオサイエンシズ (Fortress Biotech Inc.) コロナド・バイオサイエンシズ

 FBIOのチャート


 FBIOの企業情報

symbol FBIO
会社名 Fortress Biotech Inc (コロナド・バイオサイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 フォートレス・バイオテック(Fortress Biotech Inc.) は新規医薬品バイオテクノロジー製品を取得、開発、および商業化するバイオ医薬品会社である。特定の子会社を通じて製品を開発し、商品化する。Fortressには、免疫腫瘍学、血液学、遺伝子治療、疼痛管理、希少疾患及び皮膚科の6つの治療領域を対象とした、4つの商業ステージプログラム、25の開発ステージプログラムを含む11の事業子会社がある。Fortressは、内部開発プログラムに加えて、バイオ医薬ビジネスの専門知識と医薬品開発能力を活用し、Fortress Companiesを支援するための資金調達と管理サービスを提供する。同社の子会社には、Aevitas Therapeutics Avenue Therapeutics Caelum Biosciences Cellvation Inc. Checkpoint Therapeutics Cyprium Therapeutics Helocyte Inc. Journey Medical Corporation Mustang Bio National Holdings Corp 及び Tamid Bio Inc.を含む。   コロナド・バイオサイエンシズは、米国の生物学的薬剤メ―カ―。自己免疫疾患および癌の治療のための免疫療法と薬剤の開発に焦点を当てる。臨床開発段階の主要な製品候補は、クロ―ン病、潰瘍性大腸炎、多発性硬化症などの自己免疫疾患の治療向けCNDO-201、急性骨髄性白血病の治療向けCNDO-109。   
本社所在地 2 Gansevoort Street 9th Floor New York NY 10014 USA
代表者氏名 Lindsay A. Rosenwald Lindsay A. Rosenwald
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 781-652-4500
設立年月日 38869
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 45人
url www.fortressbiotech.com
nasdaq_url https://www.nasdaq.com/symbol/fbio
adr_tso
EBITDA EBITDA(百万ドル) -117.12600
終値(lastsale) 1.37
時価総額(marketcap) 74449346.93
時価総額 時価総額(百万ドル) 52.44603
売上高 売上高(百万ドル) 211.46400
企業価値(EV) 企業価値(EV)(百万ドル) -0.92697
当期純利益 当期純利益(百万ドル) -37.95800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Fortress Biotech Inc revenues increased 25% to $119.3M. Net loss increased 45% to $42.6M. Revenues reflect National segment increase of 21% to $106.5M Dermatology Product segment increase of 99% to $12.2M. Higher net loss reflects Research and developement increase from $15.6M to $39.3M (expense) Total National operating expenses increase of 17% to $107.1M (expense).

 FBIOのテクニカル分析


 FBIOのニュース

   DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm  2021/01/25 14:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $FBIO #FBIO--DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc.
   FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class Action - FBIO  2021/01/23 20:16:06 MarketScreener
NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. between December 11, 2019 and October…
   The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)  2021/01/22 16:30:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $FBIO #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
   INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2021/01/22 14:00:00 Benzinga
LOS ANGELES , Jan. 22, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fortress Biotech, Inc. ("Fortress" or "the Company") (NASDAQ: FBIO ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated thereunder by the U.S. Securities and Exchange Commission. … Full story available on Benzinga.com
   Fortress Biotech, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Stocks News Feed  2021/01/21 00:25:08 Stocks News Feed
Investors with losses are encouraged to contact the firm before January 26, 2021; click here to submit trade information LOS ANGELES, Jan. 20, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Fortress Biotech, Inc. (NASDAQ:FBIO) investors that acquired shares between December 11,… Read More »Fortress Biotech, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
   ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FBIO  2021/01/09 21:03:00 PR Newswire
NEW YORK, Jan. 9. 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the "Class Period"), of the important January 26, 2021 lead…
   ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIO - Stocks News Feed  2021/01/02 15:34:00 Stocks News Feed
NEW YORK, Jan. 02, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ:FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit… Read More »ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO
   FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Stocks News Feed  2020/12/31 17:00:00 Stocks News Feed
NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc. (“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December… Read More »FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021
   Are You An Investor Who Has Lost Money In K12 or Fortress Biotech? Kehoe Law Firm, P.C. Class Action Investigations  2020/12/18 15:09:33 EIN News
K12 Investors Who Have Lost More Than $100,000 & Fortress Biotech Investors Who Have Lost More Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
   ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIO  2020/12/18 03:00:00 Benzinga
NEW YORK , Dec. 17, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO ) between December 11, 2019 and October 9, 2020 , inclusive (the "Class Period"), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http://www.rosenlegal.com/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or Full story available on Benzinga.com
   ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIO - Stocks News Feed  2021/01/02 15:34:00 Stocks News Feed
NEW YORK, Jan. 02, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ:FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit… Read More »ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO
   FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Stocks News Feed  2020/12/31 17:00:00 Stocks News Feed
NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc. (“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December… Read More »FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021
   Are You An Investor Who Has Lost Money In K12 or Fortress Biotech? Kehoe Law Firm, P.C. Class Action Investigations  2020/12/18 15:09:33 EIN News
K12 Investors Who Have Lost More Than $100,000 & Fortress Biotech Investors Who Have Lost More Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
   ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIO  2020/12/18 03:00:00 Benzinga
NEW YORK , Dec. 17, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO ) between December 11, 2019 and October 9, 2020 , inclusive (the "Class Period"), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http://www.rosenlegal.com/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or Full story available on Benzinga.com
   Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)  2020/12/16 17:30:00 PR Newswire
LOS ANGELES, Dec. 16, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming January 26, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased or otherwise acquired Fortress Biotech, Inc. ("Fortress" or the…

 関連キーワード  (医薬品 米国株 コロナド・バイオサイエンシズ FBIO Fortress Biotech Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)